Integration of B-cell receptor-induced ERK1/2 phosphorylation and mutations of SF3B1 gene refines prognosis in treatment-naïve chronic lymphocytic leukemia

• Chiara Cavallini,
• Carlo Visco,
• Santosh Putta,
• Davide Rossi,
• Elda Mimiola,
• Norman Purvis,
• Ornella Lovato,
• Omar Perbellini,
• Erika Falisi,
• Monica Facco,
• Livio Trentin,
• Maria G. Romanelli,
• Gianpietro Semenzato,
• Achille Ambrosetti,
• Gianluca Gaidano,
• Giovanni Pizzolo,
• Alessandra Cesano,
• Maria T. Scupoli

Affiliations

Chiara Cavallini

Research Center LURM, University of Verona, Italy

Carlo Visco

Department of Cell Therapy and Hematology, San Bortolo Hospital, Vicenza, Italy

Santosh Putta

Qognit Inc., Foster City, CA, USA

Davide Rossi

Hematology, Oncology Institute of Southern Switzerland and Institute of Oncology Research, Bellinzona, Switzerland

Elda Mimiola

Department of Medicine, Section of Hematology, University of Verona, Italy

Norman Purvis

Pierian Biosciences, Franklin, TN, USA

Ornella Lovato

Research Center LURM, University of Verona, Italy

Omar Perbellini

Department of Cell Therapy and Hematology, San Bortolo Hospital, Vicenza, Italy

Erika Falisi

Department of Cell Therapy and Hematology, San Bortolo Hospital, Vicenza, Italy

Monica Facco

Department of Medicine, Hematology and Clinical Immunology Branch, University of Padua, Italy

Livio Trentin

Department of Medicine, Hematology and Clinical Immunology Branch, University of Padua, Italy

Maria G. Romanelli

Department of Neurosciences, Biomedicine and Movement Sciences, Section of Biology and Genetics, University of Verona, Italy

Gianpietro Semenzato

Department of Medicine, Hematology and Clinical Immunology Branch, University of Padua, Italy

Achille Ambrosetti

Department of Medicine, Section of Hematology, University of Verona, Italy

Gianluca Gaidano

Department of Translational Medicine, Division of Hematology, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy

Giovanni Pizzolo

Department of Medicine, Section of Hematology, University of Verona, Italy

Alessandra Cesano

NanoString, Inc, Seattle, WA, USA

Maria T. Scupoli

Research Center LURM, University of Verona, Italy;Department of Medicine, Section of Hematology, University of Verona, Italy